Mental state deterioration after switching from brand-name to generic olanzapine in an adolescent with bipolar affective disorder, autism and intellectual disability: a case study

por Samuel, Rani, Attard, Azizah, Kyriakopoulos, Marinos
Publicado 2013

Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report

por Patel, Sachin S, Attard, Azizah, Jacobsen, Pamela, Shergill, Sukhi
Publicado 2010

Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: A review of the literature

por Patel, Sachin S, Attard, Azizah, Jacobsen, Pamela, Shergill, Sukhi
Publicado 2010

Brugada syndrome: should we be screening patients before prescribing psychotropic medication?

por Attard, Azizah, Stanniland, Claire, Attard, Stephen, Iles, Andrew, Rajappan, Kim
Publicado 2022

Olanzapine long-acting injection, discontinuation rates and reasons for discontinuation: 10 years’ experience at a UK high-secure hospital

por Attard, Azizah, Wakelam, John, Broyd, Josephine, Taylor, David, Hafferty, Jonathan
Publicado 2022